Pillstats
OTC · Solution · Respiratory (Inhalation)

Racepinephrine Hydrochloride

Brands: Nebuclear Md · S2 · Racepinephrine Hydrochloride

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)66887
US makers2 labelers
Packages3
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

8621.7K2.6K3.4K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.4K
Rx · 2026 Q1
1.7K
Units dispensed
-18%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Blue Echo Care LLCunknown2SUPPLYING
Nephron Pharmaceuticals Corporationunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 13, 2023
    RECALLRecall (Class II): S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil pouc…

    Short Fill — Recalling firm: Nephron Sc Inc — Nationwide within the United States including Puerto Rico. Guatamala

  • Jun 29, 2022
    RECALLRecall (Class II): Racepinephrine Inhalation Solution, USP 2.25%, Bronchodilator, For Oral Inhalation Only, Sulfite Free, Preservative Fre…

    CGMP Deviations: products were stored outside the drug label specifications. — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — Nationwide in the USA.